Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates

被引：22
作者：
Jain, Amita [1 ]
Dixit, Pratima [1 ]
Prasad, Rajendra [2 ]
机构：
[1] CSM Med Univ, Dept Microbiol, Lucknow 226003, Uttar Pradesh, India
[2] CSM Med Univ, Dept Pulm Med, Lucknow 226003, Uttar Pradesh, India
来源：
TUBERCULOSIS | 2012年 / 92卷 / 05期
关键词：
M; tuberculosis; Drug resistance; MDR-TB; XDR-TB; Pre-; 2ND-LINE DRUG-RESISTANCE; MULTIDRUG; SURVEILLANCE; PREVALENCE; PATTERNS; STATE;
D O I：
10.1016/j.tube.2012.05.010
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Resistance to second line anti tubercular drugs is a cause of serious concern. The present study reports the prevalence of Ofloxacin (OFX) and Kanamycin (KM) resistance in Mycobacterium tuberculosis isolates from cases of pulmonary tuberculosis, who received anti tubercular treatment for >4 weeks in past. Of total 438 enrolled patients, 361 were culture positive for M. tuberculosis, of which, 95 (26.3%) were OFX resistant & 49 (13.5%) were KM resistant. Total 130 isolates were Multidrug resistant, of which, 55 (42.3%) were resistant to either OFX or KM (Pre-XDR) & 11 (8.5%) were resistant to both KM & OFX (XDR). Resistance to quinolones & aminoglycosides should be routinely assessed in areas endemic for tuberculosis. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：404 / 406
页数：3
相关论文
共 50 条
  • [41] Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance
    Igarashi, Yuriko
    Chikamatsu, Kinuyo
    Aono, Akio
    Yi, Lina
    Yamada, Hiroyuki
    Takaki, Akiko
    Mitarai, Satoshi
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (04) : 276 - 281
  • [42] Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai
    Adwani, Sameer
    Desai, Unnati D.
    Joshi, Jyotsna M.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2016, 5 (03) : 13 - 19
  • [43] Study prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Tuberculosis in East Azerbaijan province of Iran
    Mehdi, Roshdi Maleki
    Reza, Moaddab Seyyed
    Mohammad, Rahbar
    HEALTHMED, 2012, 6 (09): : 3091 - 3094
  • [44] Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019
    Bu, Qingting
    Qiang, Rong
    Fang, Lingyan
    Peng, Xiaokang
    Zhang, Hua
    Cheng, Hua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [45] Multidrug resistance (MDR) of Mycobacterium tuberculosis in France since 1992
    Robert, J
    Trystram, D
    Truffot, C
    Grosset, J
    MEDECINE ET MALADIES INFECTIEUSES, 2003, 33 : 183S - 187S
  • [46] Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus
    Riccardi, N.
    Pontarelli, A.
    Alagna, R.
    Saderi, L.
    Ferrarese, M.
    Castellotti, P.
    Viggiani, P.
    Cirillo, D.
    Besozzi, G.
    Sotgiu, G.
    Codecasa, L.
    PUBLIC HEALTH, 2020, 180 : 17 - 21
  • [47] Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis
    Madhav, Bhumika
    Iyer, Aparna
    Jayalakshmi, T. K.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation
    Caminero, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (08) : 869 - 877
  • [49] Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India
    Kaur, Simerpreet
    Rana, Vibhuti
    Singh, Pooja
    Trivedi, Garima
    Anand, Shashi
    Kaur, Amanpreet
    Gupta, Pawan
    Jain, Amita
    Sharma, Charu
    TUBERCULOSIS, 2016, 96 : 96 - 101
  • [50] The Construction of Carbon Nanotubes Containing an Anti-Bacterial Chemical Component and its Effect on MDR and XDR Isolates of Pseudomonas Aeruginosa
    Banihashemi, Kamelia
    Sobouti, Behnam
    Mehregan, Iraj
    Bakhtiari, Ronak
    Amirmozafari, Nour
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 9 (01): : 89 - 96
12345